CoMind, founded by James Dacombe, has raised $60 million in fresh funding to accelerate its mission of building non-invasive brain-computer interfaces (BCIs) that enable seamless communication between humans and machines. The round was led by Plural, with participation from Angelini Ventures, Octopus Ventures, and LocalGlobe  -  a formidable lineup that underscores global confidence in CoMind’s groundbreaking approach to neurotechnology.

This raise positions CoMind among the top innovators driving the next wave of human-AI symbiosis, where technology doesn’t replace human cognition  -  it amplifies it.

---

The Future of Brain Interfaces Is Non-Invasive

While much of the media hype around BCIs has focused on invasive implants, CoMind is taking a different path  -  one that prioritizes safety, scalability, and accessibility. The company’s proprietary neuroimaging and signal-processing technology allows for real-time decoding of brain activity without surgery or implants, using a compact, wearable device.

This approach makes neural data acquisition as simple as wearing headphones, transforming a process once limited to labs into something commercially viable for healthcare, productivity, and human augmentation.

“Our mission is to make brain interfaces as natural and accessible as smartphones,” said James Dacombe, founder and CEO of CoMind. “The brain shouldn’t need invasive modification to communicate with machines  -  it only needs understanding.”

---

How CoMind’s Technology Works

At the heart of CoMind’s platform lies a combination of advanced optical imaging, AI-driven signal decoding, and adaptive neural mapping. The system reads blood flow and electrical signals in the brain, translating them into actionable data in milliseconds.

This enables potential applications like:

• Hands-free control of digital interfaces using thought-based commands.
  
• Neurofeedback for mental health, helping users regulate focus, mood, and stress.
  
• Cognitive enhancement tools that adapt learning and work environments based on real-time brain activity.
  
• Clinical diagnostics for neurological conditions, reducing reliance on bulky and costly imaging systems.
  

By integrating these technologies into a lightweight wearable, CoMind is pioneering the first commercially scalable approach to reading the mind  -  without ever opening the skull.

---

Deep Insight: Why Accessibility Wins in Frontier Tech

CoMind’s approach offers an important strategic lesson for deep-tech founders: accessibility is innovation’s multiplier. The most transformative technologies  -  from the personal computer to the smartphone  -  succeeded not because they were the most advanced, but because they were the most accessible.

In frontier fields like neurotech, accessibility means designing for comfort, usability, and integration, not just performance. While invasive BCIs may achieve granular precision, they face massive barriers in regulation, adoption, and scalability. CoMind’s bet is that mass-market success will favor technologies that are frictionless and inclusive.

This principle applies across sectors: founders building deep-tech solutions must think not only about “how it works,” but “who can actually use it.” The difference often determines whether an innovation becomes a niche experiment or a global paradigm shift.

---

Investor Confidence and Strategic Support

The funding from Plural, Angelini Ventures, Octopus Ventures, and LocalGlobe reflects both the scale of CoMind’s vision and the growing investor appetite for technologies bridging human cognition and artificial intelligence.

These investors bring expertise across life sciences, AI, and frontier hardware  -  giving CoMind the resources to scale from prototype to platform. The funds will be used to:

• Advance R&D in AI-driven neural decoding and signal precision.
  
• Expand CoMind’s clinical and commercial trials in Europe and North America.
  
• Grow its hardware engineering and neuroscience teams.
  
• Begin partnerships with leading universities and medical institutions for validation studies.
  

This investor mix also positions CoMind at the intersection of AI innovation and neuroscience commercialization, two sectors projected to exceed $200 billion in combined annual value by 2030 (CB Insights).

---

Redefining the Human-AI Interface

At its core, CoMind envisions a world where interaction with technology becomes effortless, intuitive, and embodied. Instead of keyboards, screens, and voice assistants, CoMind’s BCI technology allows users to transmit intent directly  -  a silent, seamless form of communication between the mind and machine.

Early testing shows promising results in real-time mental state tracking and intent recognition, opening the door to applications in education, gaming, mental health, and human performance optimization.

This aligns with broader global trends:

• The global BCI market is projected to grow from $2.5 billion in 2023 to over $15 billion by 2030 (Fortune Business Insights).
  
• Non-invasive interfaces represent the fastest-growing segment, expected to capture over 70% of market share due to ease of use and ethical acceptance.
  
• Healthcare, defense, and consumer tech are converging rapidly around human enhancement and brain-data integration.
  

CoMind’s non-invasive model positions it as a critical enabler of this convergence  -  offering the same transformative potential as Neuralink or Synchron, but without the surgical risks.

---

A Safer, Smarter Future for Neurotechnology

Ethics and safety remain central to CoMind’s philosophy. The company is committed to ensuring data privacy, informed consent, and ethical usage of brain-derived information.

By focusing on non-invasive technology, CoMind not only sidesteps the medical risks of surgical BCIs but also creates a more socially acceptable pathway to mainstream adoption. This ethical stance could prove decisive as public and regulatory scrutiny intensifies in the AI and neurotech sectors.

“Understanding the brain is humanity’s next great frontier,” said Dacombe. “But it’s one we must explore responsibly  -  with empathy, consent, and trust.”

---

What’s Next for CoMind

With its $60 million funding, CoMind is now entering an expansion phase. The company plans to:

• Launch its first developer platform, allowing third parties to build applications using CoMind’s neural APIs.
  
• Continue validation with academic and clinical partners in the U.K. and the U.S.
  
• Develop new hardware prototypes optimized for comfort, accuracy, and extended wear.
  
• Explore AI integrations for adaptive learning, emotion recognition, and mental state monitoring.
  

As CoMind scales, it aims to make brain-based interfaces an everyday tool  -  not a futuristic fantasy.

---

Human-Centric Intelligence: The True North of AI

CoMind’s mission captures the essence of what many believe will define the next decade of AI: technology that learns from humans, for humans.

By bridging neuroscience and AI, the company isn’t just creating a product  -  it’s helping define a new interface paradigm where thought, emotion, and computation blend seamlessly.

In an era where the boundary between human and machine intelligence is rapidly dissolving, CoMind offers a vision rooted in harmony, not dominance  -  where the mind leads, and the machine listens.